Suspended

MAINZ-EPIREGStudy on Disease Course and Quality of Life in Patients With Epilepsy (Mainz Epilepsy Registry)

What is being collected

Data Collection

Collected from today forward - Prospective

Who is being recruted

Psychogenic Nonepileptic Seizures+7

+ Brain Diseases

+ Central Nervous System Diseases

Over 18 Years

+3 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.

Observational

Study Start: February 2018

See protocol details

Summary

Principal SponsorJohannes Gutenberg University Mainz

Study ContactYaroslav Winter, MD, MSc

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2018

Actual date on which the first participant was enrolled.

Clinical parameters of patients, such as onset of the disease, prior medication, disease severity, which are important for the data analysis also collected retrospectively before the initiation of the registry. Data on the quality of life is collected only prospectively.

Official TitleStudy on Disease Course and Quality of Life in Patients With Epilepsy (Mainz Epilepsy Registry)

NCT05267405

Principal SponsorJohannes Gutenberg University Mainz

Study ContactYaroslav Winter, MD, MSc

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

700 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Psychogenic Nonepileptic SeizuresBrain DiseasesCentral Nervous System DiseasesEpilepsyNervous System DiseasesNeurologic ManifestationsSeizuresSigns and SymptomsStatus EpilepticusPathological Conditions, Signs and Symptoms

Criteria

1 inclusion criteria required to participate

Epileptic or psychogenic seizures

2 exclusion criteria prevent from participating

age<18

patients who cannot provide informed consent and don't have a legal guardian

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Mainz Comprehensive Epilepsy and Sleep Medicine Center

Mainz, GermanyOpen Mainz Comprehensive Epilepsy and Sleep Medicine Center in Google Maps

SuspendedOne Study Center